disorders are themselves associated with increases in the risk of suicide. Patients of all ages tofranil for menopause are started on tofranil for menopause therapy should be monitored appropriately and observed closely for clinical tofranil for menopause suicidality, or unusual changes in behavior. Families and caregivers tofranil for menopause be advised.

of congestive heart failure, stroke. king, feeling, and tofranil for menopause with excitement and activity you cannot control.Psychiatric: Confusional states (especially in the elderly) with hallucinations, disorientation, delusions; anxiety, restlessness, agitation; insomnia and nightmares; tofranil for menopause exacerbation of psychosis.Neurological: Numbness, tingling, paresthesias of extremities; incoordination, ataxia, tofranil for menopause peripheral neuropathy; extrapyramidal symptoms; seizures, alterations tofranil for menopause EEG patterns; tinnitus.Anticholinergic: Dry tofranil for menopause and rarely, associated sublingual adenitis; blurred vision, disturbances of accommodation, mydriasis; constipation, tofranil for menopause ileus; urinary retention, delayed micturition, dilation of the urinary track.Allergic: Skin rash, petechiae, urticaria, itching, photosensitization, edema (general or of face and tongue); drug fever; cross-sensitivity with tofranil for menopause Bone marrow tofranil for menopause including agranulocytosis; tofranil for menopause tofranil for menopause thrombocyenia.Gastrointestinal: Nausea.

in children being treated for bedwetting are:Nervousness, sleep disorders, stomach tofranil for menopause intestinal.